3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
3
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
514
Leukemia
340
Leukemia, Lymphocytic, Chronic, B-Cell
322
Precursor Cell Lymphoblastic Leukemia-Lymphoma
291
Myelodysplastic Syndromes
235
Lymphoma, Non-Hodgkin
173
Lymphoma
162
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Hematologic Neoplasms
133
Multiple Myeloma
121
Lymphoma, Follicular
120
Lymphoma, Large B-Cell, Diffuse
119
Lymphoma, Mantle-Cell
118
Recurrence
115
Hodgkin Disease
99
Burkitt Lymphoma
99
Lymphoma, B-Cell, Marginal Zone
98
Leukemia, Myelomonocytic, Chronic
78
Congenital Abnormalities
78
Leukemia, Myeloid, Chronic-Phase
68
Neoplasms
67
Myeloproliferative Disorders
66
Lymphoma, Large-Cell, Immunoblastic
64
Blast Crisis
59
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
57
Waldenstrom Macroglobulinemia
53
Primary Myelofibrosis
53
Lymphoma, T-Cell, Cutaneous
52
Leukemia, Myeloid, Accelerated Phase
50
Neoplasms, Plasma Cell
48
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Chromosome Aberrations
×
Other hematologic neoplasm
×
Clear all
NCT00461929
2009-02-13
GIST
University Health Network, Toronto
Phase 4
Terminated
68 enrolled